Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone Influenza Virus Vaccine (2005-2006 Formulation)
Phase of Trial: Phase IV
Latest Information Update: 08 Apr 2014
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sanofi; sanofi pasteur
- 27 Apr 2010 Official Title amended as reported by ClinicalTrials.gov.
- 21 Sep 2008 Actual patient number (30) added as reported by ClinicalTrials.gov
- 21 Sep 2008 Actual end date (1 Aug 2007) added as reported by ClinicalTrials.gov.